Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

Otsuka Pharmaceutical identifies AhR antagonists

March 25, 2020

Desmopressin shows promise for the management of bleeding in rectal cancer

March 20, 2020

Cellphire cleared to begin phase II study of Thrombosomes in bleeding patients with thrombocytopenia

March 19, 2020

Novo Nordisk announces decision to pause concizumab trials in hemophilia

March 17, 2020

Keeping stem cells quiescent enables greater ultimate potency

March 10, 2020

BioCryst initiates proof-of-concept trial of BCX-9930 in PNH

March 6, 2020

Omeros reports new data from pivotal trial of narsoplimab for HSCT-TMA

March 3, 2020

Phase I data for novel lentiviral vector therapy for children with Fanconi anemia

Feb. 28, 2020

Bluebird bio presents phase I/II data on LentiGlobin for sickle cell disease

Feb. 25, 2020

Phase IIb results presented for dalcinonacog alfa in hemophilia B patients

Feb. 12, 2020

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...